DHA/AA Addition To Infant Formula Not Recommended By LSRO
This article was originally published in The Tan Sheet
Executive Summary
Evidence supporting the benefits of arachidonic acid and docosahexaenoic acid in term infant formulas is "insufficient" to warrant a recommendation that the long-chain polyunsaturated fatty acids be added to FDA's nutrient content standards for the products, the American Society for Nutritional Sciences Life Sciences Research Office concludes in a recent report.
You may also be interested in...
LCPUFAs Show No Effect On Infant Cognitive/Motor Development In Study
The addition of n-3 and n-6 long-chain polyunsaturated fatty acids (LCPUFAs) arachidonic acid (AA) and docosahexaenoic acid (DHA) to infant formula did not result in any effect on cognitive and motor development or growth in infants for up to a year-and-a-half, Alan Lucas, MRC Childhood Nutrition Research Centre, London, et al., conclude in a study published in the Dec. 4 issue of The Lancet.
LCPUFAs Show No Effect On Infant Cognitive/Motor Development In Study
The addition of n-3 and n-6 long-chain polyunsaturated fatty acids (LCPUFAs) arachidonic acid (AA) and docosahexaenoic acid (DHA) to infant formula did not result in any effect on cognitive and motor development or growth in infants for up to a year-and-a-half, Alan Lucas, MRC Childhood Nutrition Research Centre, London, et al., conclude in a study published in the Dec. 4 issue of The Lancet.
LCPUFAs Show No Effect On Infant Cognitive/Motor Development In Study
The addition of n-3 and n-6 long-chain polyunsaturated fatty acids (LCPUFAs) arachidonic acid (AA) and docosahexaenoic acid (DHA) to infant formula did not result in any effect on cognitive and motor development or growth in infants for up to a year-and-a-half, Alan Lucas, MRC Childhood Nutrition Research Centre, London, et al., conclude in a study published in the Dec. 4 issue of The Lancet.